Roche Holding AG (RHHVF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:55PM EDT
| Previous close | 233.27 |
| Open | 233.50 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 233.50 - 244.92 |
| 52-week range | 233.12 - 323.78 |
| Volume | |
| Avg. volume | 9,898 |
| Market cap | 203.429B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 15.42 |
| EPS (TTM) | 15.82 |
| Earnings date | 25 July 2024 |
| Forward dividend & yield | 10.86 (4.66%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.